Coromandel International stock reports a 24.59 percent profit drop

Coromandel International stock is anchored by a sharp earnings contrast in Q1 FY27: revenue reached INR 8,164.77 crore, while profit after tax fell 24.59 percent year over year to INR 380.82 crore. The company has also set a corporate trading restriction ahead of its September quarter and half-year results.

Q1 revenue grows, profit contracts

According to Tickertape in its Q1 FY27 financial update, revenue from operations rose 15.94 percent from INR 7,042.30 crore in the year-earlier quarter to INR 8,164.77 crore in the quarter ended June 2026.

The earnings mix was weaker. Profit before tax declined 24.15 percent to INR 513.68 crore, while profit after tax dropped from INR 505.01 crore to INR 380.82 crore. Raw-material and packing-material costs rose 29.39 percent to INR 4,615.19 crore, increasing pressure on profitability even as sales expanded.

The business lines moved at different speeds. Nutrient and other allied revenue increased 9.44 percent year over year to INR 6,951.03 crore, while crop protection revenue surged 72.55 percent to INR 1,250.76 crore. That split gives investors a clear operational counterweight to the decline in consolidated profit.

Trading window sets next checkpoint

Tickertape reports that Coromandel International will close its securities trading window from October 1, 2026, until 48 hours after the unaudited results for the quarter and half-year ending September 30, 2026. The announcement was dated September 26, 2026.

That calendar item matters because the next report will show whether stronger crop protection growth can offset fertilizer margin pressure. The June quarter established the comparison: revenue rose 15.94 percent, but profit after tax declined 24.59 percent.

Market value reaches INR 516.4 billion

Coromandel International had a market capitalization of INR 516.4 billion on September 30, 2026. The structured market quote showed an INR 1,709.50 to INR 2,496.10 52-week range for the same date, placing the company within a broad valuation band while operating results remain uneven.

Coromandel describes its business as an agribusiness platform spanning fertilizers, crop protection, specialty nutrients and retail. Its investor-relations page highlights innovation, sustainability and shareholder reporting as part of the company strategy.

Results remain the market checkpoint

For investors, the central measure is the balance between volume-led revenue growth and cost absorption. Coromandel International's September 2026 results will provide the next quantified test of that balance after the June quarter delivered higher sales but lower earnings.